periodontitis in diabetic patients, seemingly stressed by poor glycemic control (I). Poorly controlled type 2 diabetes seems to promote the expression of inflammatory mediators such as tumor necrosis factor (TNF)-alpha, interleukin (lL)-6 and -8, chemokine receptor (CCR) -5, and CXC chemokine receptors -3 in sites with chronic periodontitis (2) . From a clinical point of view, poorly controlled Type 2 diabetes and alveolar bone loss appear to be strongly related, with a bidirectional relationship (3) . Moreover, a clear relationship between bone resorption rate and subgingival microflora has been conclusively established (4) .
Although dental implant therapy presents longterm predictability, peri implant attachment and environment are similar to the periodontal one, and can be affected by pathologic inflammatory conditions (5) .
Similarly to natural teeth, the intra-pocket microbiological niche can affect the health of periimplant tissues, promoting the development of mucositis and peri-implantitis (6) . Peri-implant supracrestal marginal tissues seem to react to plaque bacteria similarly to periodontal ones, but with an inflammatory cell infiltrate (lCT) more pronounced than in periodontal lesions and located apically in respect to the junctional epithelium (7) . Diabetic patients seem to be more prone to periimplantitis, in comparison with the healthy population (8, 9) . NIDDM patients may have -in addition to a proinflammatory phenotype -a highly pathogenic microflora, due to advanced glycosilation end product (AGE) accumulation in gingival crevicular fluid (GCF), although this fact remains controversial (10) .
The purpose of this study was to analyze periimplant microbial samples of healthy versus NIDDM patients and relate microbiological findings with plaque index (PI), bleeding on probing (BOP), probing pocket depth (PPD), as well as implant stability quotient (lSQ) and radiographic marginal bone loss (MBL).
MATERIALS AND METHODS

Patient selection
Patients treated for partial edentulism in the period from February 2009 to March 2010 at the Prosthodontics Operative Unit of "Sapienza" University of Rome, with no history of systemic disease, or affected by NIDOM were selected. All patients received root-form, titanium, osseointegrated dental implants, loaded with a delayed protocol, and had at least two years of follow-up at the beginning of the present research. The patients at the recruitment for implant therapy showed Full Mouth Plaque Score (FMPS) and Full Mouth Bleeding Score (FMBS) <25%, and absence of periodontal disorders.
At the starting point of the current study, the patients selected were required to have availability of complete clinical records, including clinical photographs, panoramic radiographs and sometimes computed tomography (CT Dentascan), as needed; information on bone density as evaluated during osteotomy according to a four-tiered scale: high density (type I), moderate density (type II), low density (type III), and very low density (type IV) (11); furthermore, periapical radiographs and clinical as well as microbiological parameters taken at each followup recall had to be available.
Laboratory and clinical parameters
All subjects underwent preoperative haematological examination, with particular attention to the parameters complete blood count (CBC), erythrocyte sedimentation rate (ESR), cholinesterase, c-reactive protein (CRP), blood glucose levels, glycated haemoglobin, fibrinogen, prothrombin rate, partial thromboplastin time, alanine aminotransferase (ALT).
Clinical examination included the detection ofpossible pain, discomfort or mobility as well as the previously listed periodontal parameters (PI, BOP, PPD) recorded at mesio-buccal, mid-buccal, disto-buccal, and mid-lingual implant surfaces.
PI was recorded as presence or absence of soft deposits, on four surfaces per implant, and calculated as ratio between involved and examined surfaces. BOP was recorded as presence or absence of bleeding through gentle probing at the bottom of the pocket using a 15-mm periodontal probe (XP23IUNCI5, Hu-Friedy, Chicago, IL, USA). A detectable bleeding within 10 seconds was considered a positive finding and the number of positive sites was calculated for each patient, in relation to examined ones. PPO was calculated as mean value for each patient.
Resonance Frequency Analysis (RFA) expressed as ISQ units, ranging from 1 (low stability) to 100 (high stability), was recorded for each implant by means of a specific device (Osstell ISQ, Goteborg, Sweden) .
Implant success was evaluated according to Albrektsson et al. criteria (12) , updated and integrated by Misch et al. (13) . All evaluations were performed at 3-month (T\), 6-month (T z ), 12-month (T) and 24-month (T 4 ) follow-up.
Radiographic evaluation
Peri-implant MBL was evaluated on standardized periapical radiographs, taken at T 1 , T z ' T 3 and T 4 and digitalized with a high-resolution scanner (Fig 1) . '
With image analysis software (Scion Image 4.02 Win, Scion corporation, Frederick, MD), able to compensate radiographic distortion, the distance from the mesial and distal margin of the implant neck to the most coronal bone-to-implant contact was measured, and the average of mesial and distal values was considered for each implant. The software was calibrated by referring to the known vertical distance between two consecutive implant threads. All measurements (periodontal indices, radiographic measurements) were made and collected by the same single trained examiner not associated with the implant surgeons, and blind regarding to which groupdiabetic or healthy -the patient belonged to.
Microbiological parameters
Microbiological evaluation was carried out through 3 to 5 sampling points for each peri-implant sulcus, selecting areas with the deepest PPD, in order to reach with certainty the bottom of the pocket. .
A sterile absorbent endo paper point was placed at each selected sampling site and left there for about 30 seconds, taking care to prevent saliva contamination by isolating the operative field with cotton rolls and gauze pieces. Then paper cones were placed in the tube-like container provided by the diagnostic kit (Carpegen Perio Diagnostics, Munster, Germany) and sent to the specialized laboratory for analysis (Carpegen GmbH, MendelstraBe 11, Munster, Germany). Specifically, the presence and the bacterial counts for Aggregatibacter actinomycetemcomitans (A.a.), Porphyromonas gingivalis (Pg.), Tannerella forsythia (Tj), Treponema denticola (T'd.), Fusobacterium nucleatum (F.n.) and Prevotella intermedia (Pi.) were investigated. Bacterial counts were calculated by comparison with homologous reference standards and expressed as count x10 5 . Microbiological evaluation was performed at T 1 , T z ' T 3 and T 4 .
Statistical analysis
The dependent variables of interest were periodontal parameters such as PI, BOP, PD and MBL, positive findings for A.a., r«: Tj, rd, F.n. and Pi. bacteria and their respective microbial counts. The number of peri-implant sites positive to pathogens in systemically healthy and diabetic patients was reported as descriptive data. The log-transformed counts of the target organisms in positive samples were plotted in a box-plot and mean values with standard deviations (SD) were calculated for the two considered populations. A multiple linear regression analysis was carried out in order to identify significant differences for the clinical parameters (BOP, MBL, ISQ) as well as microbiological counts between healthy and NIDDM groups, controlling the effects of additional covariates such as PI, PD, smoking habit (yes or non), patient's age, bone density as clinically evaluated during osteotomy (BD), and implant position as regards arch (maxilla versus mandible), and implant locations within arch (anterior versus posterior). The interactions between the groups and these covariates, as well as the single effects, were tested by Student t-tests with a level of significance set to 5%, at all four follow-up times. Analyses were performed by using Statistical Package for Social Sciences, version 11.0 (SPSS Inc., Chicago, IL, USA).
RESULTS
Thirty partially edentulous patients (15 females and 15 males, mean age 55.8±7.41 years, range 40-70 years), consecutively treated from February 2009 to March 2010 at Prosthodontics Operative Unit of "Sapienza" University of Rome, fulfilled the selection criteria.
The overall population of patients included 22 systemically healthy subjects with 51 implant sites (group 1) and eight patients with NIDDM, who received 15 implants (group 2). All patients were treated with the same implant-abutment system (Blue sky, Bredent Medical GmbH & Co.KG, Senden, Germany).
Laboratory analyses
Haematological examination revealed statistically significant differences between the two populations only for glycated haemoglobin (5.95±0.65 vs 9.05±1.07; P<O.OOOl) and fasting glucose level (88.80±2.24 vs 132±5.81; P<O.OOOl). Clinical parameters -Considering both populations, no dental implants showed pain, discomfort or mobility, and a 100% success rate was reported.
At the last (24-month) follow-up statistically significant differences were reported for the clinical parameter lSQ (p=0.0002), while differences in means between healthy and NlDDM groups for the variable BOP, MBL and PPD did not reach statistical significance (BOP: p = 0.0888; MBL: p= 0.05; PPD: p= 0.3136). The main characteristics of the patient sample, and the values of clinical parameters are detailed in Tables Ia and lb . Therefore, the linear estimates (±SD) obtained by the linear regression models were considered. In particular, when the clinical parameters were examined as outcomes with regard to the covariate effects, smoking habit appeared to be significant in relation to MBL (P<=0.002), with higher mean values of MBL for smokers at both one-year and two-year followup. Intraoperatively-measured BD showed a direct relationship with ISQ (P=0.03), while arch effect was almost significant in relation to this variable (P=0.06 at T3 and P=0.08 at T4) by showing slightly higher performances for mandibular implants. Once the covariates were taken into account, the differences between groups I and 2 for clinical parameters were evaluated. Setting group I as the reference group, when it was compared with patients of group 2, no statistically significant mean differences were observed, except for ISQ (P<=0.002).
Microbiological results
In group 1, 2 patients (9%) were positive to A.
actinomycetemcomitans, 4 (18%) to P. gingivalis, 5 (23%) to T. forsythia, 5 (23%) to T. denticola, 7
(32%) to F. nucleatum and 11 (50%) to P. intermedia.
In group 2, 2 patients (25%) were positive to A, actinomycetemcomitans, 3 (38%) to P. gingivalis, 7 (32%) to T. forsythia, 7 (88%) to T. denticola, 6
(75%) to F. nucleatum. and 5 (63%) to P. intermedia. The percentages of patients positive to the investigated pathogens at 24-month follow-up are shown in Fig. 2 for T. denticola, 2.18± 1.24 for F. nue/eatum and 1.08±0.77 for P. intermedia in group 2 (Table lIb) . The mean bacterial counts at different follow-up times are detailed in Table III and represented, as contribution of the individual groups (NIDOM and healthy), in Fig. 3 ; the average values of bacterial load, by microorganism and group, at 24-month follow-up are shown in Fig. 4 . When the microbiological results were considered with regard to the covariate effects, the regression analysis on the A. actinomycetemcomitans. P. gingivalis, T. forsythia. T. denticola, F. nue/eatum, and P. intermedia microbial counts showed no significant differences between the groups for each time interval (P >0.2). Among the considered covariates, PO seemed to slightly correlate with the presence ofA. actinomycetemcomitans, P. gingivalis (P=0.04), while the recorded values of PI were seemingly related to the detection of higher levels of T. forsythia and T. denticola (P=0.03) .
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DISCUSSION
The present research reported no statistical significant differences in clinical and microbiological periimplant profiles of healthy and NIDOM patients , supporting the hypothesis that the use of dental implant in patients with well-, or moderately wellcontrolled type 2 diabetes mellitus may be a reliable dental treatment modality (14) . Nevertheless, a slight trend was empirically noticed towards a lower clinical performance and higher bacterial load in diabetic patients, corroborating previous findings (15) .
In the present study, no difference was reported between the two groups regarding implant survival and success. Previous studies indicated a higher implant failure rate in NIDOM patients, although with well-controlled blood glucose levels, in comparison with healthy population (16) . Specifically, the implant survival rates reported in literature for NIDOM patients show great variability, ranging between 88.8% and 97.8% one year after final restoration delivery, and between 85.7% and 94.6% at five-year follow-up after prosthetic loading (17) . The fact that the highest failure rates seem to occur during the first year after restoration delivery could be due to impaired microvascular or immune function , as well as ultrastructural defects of the bone-implant interface, making the bone around the implant unable to withstand functional loading. In this study no implant failure was reported at twoyear follow-up after prosthetic loading, but the small sample size of course prevents drawing any significant conclusions in regard.
In the present research the only clinical variable that differed significantly between the two groups was the ISQ, evaluated through resonance frequency analysis and controlling for covariate arch, position and intraoperatively recorded BO. This parameter has been shown to provide a reliable longitudinal assessment of bone density, bone-to-implant contact and changes in supporting matrix (18) , and a relationship between ISQ values and glycemic control in diabetic patients has been previously reported (19, 20) . Mineral homeostasis of the extracellular matrix seems to be negatively affected by hyperglycemic status and osteoid deposition has been demonstrated to strongly decrease in several experimental models of diabetes (21) . Evaluating the impact of diabetes on dental implants, a reduced bone-to-implant contact and significantly fewer bone bridges connecting endosteum to the implant surface (22) have been noticed in murine models of diabetes mellitus. This condition appeared to be reversible by treating the hyperglycemia and maintaining wellcontrolled blood glucose levels (23) . In the current study, chronic although moderate hyperglycemia, with its ability to affect the bone-implant interface, may explain the values of ISQ of diabetic patients, statistically lower than those reported for the nondiabetic control group. When the clinical variables BOP, MBL, ISQ were sorted by PI, PO, smoking habit, patient's age, intraoperative BO, dental arch, and implant position within arch, not surprisingly (24, 25) the factors that appeared to have some influence were smoking habit for MBL and BO for ISQ. As regards microbiological results, a slight trend towards higher bacterial counts was reported in this study for NIDOM patients in comparison with non-diabetic ones, although the difference remained below the statistical significance. Interestingly, bacterial counts of A. actinomycetemcomitans and P. gingivalis showed to be influenced by the covariate PO, corroborating previous findings (26) .
Relatively few studies in literature have evaluated the specific characteristics of subgingival microflora in diabetic patients. Kumar et al. (27) reported a very similar microbiological profile for diabetic and non-diabetic populations affected by periodontitis. Ciantar et al. (28) identified significantly higher numbers of P. gingivalis, A. actinomycetemcomitans, Capnocytophaga spp. and other anaerobic bacteria in periodontitis-affected sites of diabetic subjects compared to non-diabetic ones, but these differences were also evident between affected and healthy periodontal sites. Supposedly, subtle differences in microbial load and composition can be detected in subgingival biofilm of NIDDM versus non-diabetic patients, especially in subjects with poor glycemic control, but clinical relevance of this fact has not yet been established. Of course, chronic hyperglycemia may playa role in altering the chemical environment within the periodontal/periimplant pocket so as to favour the growth of certain bacterial species (29) .
Nevertheless, the main mechanism considered to promote periodontal/peri-implant disorders in diabetic patients is an enhanced host inflammatory response to pathogens (30) . In a diabetic mice model inoculated with P. gingivalis, increased fibroblast apoptosis, diminished collagen I and III expression, as well as significantly reduced formation of connective tissue matrix, resulted in an amplified and more persistent tissue injury in comparison with non-diabetic controls (31) .
Increased gingival crevicular fluid (GCF) levels of PGE2 and IL-lP have been reported in diabetic patients in respect to healthy, matched for periodontal condition (32) . In IDOM patients, monocytes challenged with lipopolysaccharides produce significantly greater amounts ofTNF-a, ILl P and PGE2 than in non-diabetic individuals (33) .
Also functional impairment ofpolymorphonuclear leucocyte (PMN) including reduced diapedesis, chemotaxis, phagocytosis as well as defective PMN apoptosis, may lead to increased retention of PMNs in the periodontal tissue, producing an amplified tissue destruction through sustained release ofmatrix and reactive oxygen species (ROS) (34) .
Accumulation of advanced glycation end products (AGEs) enhances production of ROS and oxidative stress, with endothelial cells deterioration and subsequent vascular injury, underlying many diabetes complications. AGEs by binding to their receptor induce up-regulation of pro-inflammatory cytokines such as IL-l P, TNF-a and IL-6, amplifying tissue breakdown (35) .
In conclusion, several factors are likely to play a role in increased susceptibility subjects, affected by diabetes, to periodontal/peri-implant disorders. These factors seemingly include rather an upregulated immune response than a different composition in the subgingival microflora.
Well-controlled blood glucose level and correct maintenance through supportive periodontal care seem to be of crucial importance and to efficiently counteract the trend towards lower performance in implant therapy of diabetic patients.
Within the limitations of the present research, small sample size and brieftime ofobservation, it can be cautiously concluded that NIDDM patients show a slight trend towards a lower clinical performance of dental implant therapy, but not fully explained by the observed microbiological profile. Further well-designed studies in large series and with longtime follow-up should be performed in order to conclusively clarify this point.
